Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Genomic Biomarkers

Liquid Biopsy (Longitudinal Cell-free Plasma) - Indivumed

Read More
Biomarker Discovery & Development

RNA Sequencing - MiRXES

Read More
Genomic Biomarkers

Spatial Transcriptomics Services - Indivumed

Read More
Biomarker Discovery & Development

Whole Exome Sequencing - MiRXES

Read More
Biomarker Discovery & Development

Whole Genome Bisulphite Sequencing - MiRXES

Read More
Biomarker Discovery & Development

Whole Genome Sequencing - MiRXES

Read More
Clinical Development

Non-Invasive Biomarkers: Aiding Clinical Qualification of Prognostics and Monitoring Biomarkers for Liver Cirrhosis

In this Commentary, we explore how non-invasive biomarkers may be used to diagnose pre-symptomatic NASH in patients without them undergoing invasive biopsies.
Read More
Clinical Development

The Applicability of Clinical Biomarkers for NASH and Fibrosis

Archana Vijayakumar, Senior Research Scientist I of Fibrosis at Gilead, presents on understanding disease progression and therapeutic efficacy in preclinical models for NASH.
Read More
Clinical Development

Overcoming Challenges of NASH in Clinical Development

Vincent Mikol, Precision Medicine Head at Sanofi, leads a discussion on navigating the current challenges of NASH in clinical development.
Read More
Biomarker Discovery & Development

Treating the Untreatable: Unlocking Precision Medicine Biomarkers for NASH

Introducing PreciNASH, a multidisciplinary consortium strengthening the link between research outputs and clinical applications in NASH disease treatment.
Read More
Digital Biomarkers

Identifying Prognostic Biomarkers for Follicular Lymphoma

How can the spatial interactions of the tumour immune microenvironment reveal prognostic insights into Follicular Lymphoma? We ask Martin Fergie, Lecturer in Healthcare Sciences at the University of Manchester.
Read More
Clinical Development

The Biomarker Factory: A High-Performance Analytical Platform for Fluid Biomarker Development, Validation, and Measurement

Amanda Heslegrave, Senior Research Fellow at the UK Dementia Research Centre, UCL, showcases cutting-edge super sensitive immunoassay research at Biomarkers UK 2021.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers